Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...

The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...

The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...

It’s 7:15 a.m on the final day of the J.P. Morgan Healthcare Conference and Mike Rice, a founding partner of LifeSci Advisors, is exceedingly energetic. It’s hard to hold that against him because it’s ...

Strata Oncology might be the missing piece in personalized cancer care — if it can pull off some large-scale matchmaking. Headquartered in Ann Arbor, Michigan, the company was founded earlier this ...

In an era of tightening margins and rising complexity, some hospitals are looking to AI as a lifeline — but technology is a tool, not a silver bullet. Many organizations hope AI will be a quick fix ...

Obesity has many drivers, but for those with a particular rare metabolic disorder, the root cause is genetic. These patients develop ravenous hunger unsatisfied by any amount of food. The constant ...

Sleep.ai, a sleep intelligence platform, has raised $5.5 million in funding, which it will use to advance its AI models that analyze sleep patterns, it announced on Tuesday. The Carlsbad, ...

A quarter of Medicare spending occurs during the final year of a patient’s life. Billions of those dollars go toward care that is misaligned or unwanted, which is often due to a lack of planning for ...

Violence against healthcare workers is not a new problem, but it’s one that’s getting more severe. The Occupational Safety and Health Administration (OSHA) estimates that nearly 75% of all workplace ...

Eli Lilly is acquiring Sigilon Therapeutics, its type 1 diabetes partner, in a small deal that could pay out big later if the cell therapy developer achieves goals that show it has overcome an immune ...

Across industries, competition between a few dominant players is not unusual, but in healthcare, its effects extend well beyond standard business rivalry. When control over prescription drug access ...